Marijuana Stock Set To Rise On Your Watchlist: Verano Holdings Targets EBITDA And Lower Debt
Marijuana Stock Set To Rise On Your Watchlist: Verano Holdings Targets EBITDA And Lower Debt
Senior analyst Pablo Zuanic of Zuanic & Associates released an update on Verano Holdings (OTC:VRNOF), which is crucial for investors monitoring the cannabis sector. Verano's sales for 2023 are projected at $938.5 million, with a potential EBITDA recovery to $300.4 million by 2025. Zuanic's report indicates that Verano may achieve profitability by 2025, highlighting key financial metrics that are vital for informed investment decisions.
Zuanic＆Associates的高級分析師Pablo Zuanic發佈了Verano Holdings（OTC：VRNOF）的最新消息，這對於監測大麻板塊的投資者至關重要。預計Verano在2023年的銷售額爲9.385億美元，到2025年可能會有300.4 million的潛在EBITDA恢復。Zuanic的報告表明，Verano可能會在2025年實現盈利，強調了對了解投資決策至關重要的關鍵財務指標。
Sales Projections
銷售預測
Sales for 2023 are estimated at $938.5 million, a 7% increase from $879.4 million in 2022. Quarterly sales are projected to fluctuate, with Q2 2024 expected to see a slight rise to $225 million from $221.3 million in Q1. By 2025, sales are anticipated to reach $983.4 million.
預計2023年銷售額爲9.385億美元，比2022年的8.794億美元增長7％。季度銷售額預計會波動，2024年第二季度銷售額預計會從2021.3億美元上升至2.25億美元。到2025年，銷售額預計將達到9.834億美元。
EBITDA And Operating Income
EBITDA和營業收入
EBITDA for 2023 is forecasted at $305.5 million, declining to $280.7 million in 2024 but expected to recover to $300.4 million by 2025. The company has faced operating losses, recording -$162.7 million in 2022 but projecting an operating income of $129.1 million for 2024.
預計2023年的EBITDA爲3.055億美元，到2024年降至2.807億美元，但有望在2025年恢復到3.004億美元。該公司曾經面臨營業虧損，2022年錄得-1.627億美元，但預計2024年的營業收入爲1.291億美元。
Net Interest Expenses And Profit
淨利潤和利息費用
Net interest expenses are expected to decrease from -$59.8 million in 2023 to -$49.3 million in 2024. The net profit for 2024 is projected at -$9 million, with EPS moving from -$0.81 in 2022 to -$0.03 in 2024 and possibly turning positive by 2025. This means Verano is expected to reduce its losses and achieve profitability by 2025, reflecting improved financial health and operational efficiency.
預計淨利息費用將從2023年的-5,980萬美元降至2024年的-4,930萬美元。預計2024年的淨利潤爲-900萬美元，每股收益從2022年的-0.81美元到2024年的-0.03美元，並有可能在2025年實現正收益。這意味着Verano有望減少虧損並在2025年實現盈利，反映出財務健康和運營效率的改善。
Share Price And Market Cap
股價和市值
Verano's share price stands at $4.12, with a market cap of $1.4 billion. The company's debt levels are projected to decrease, with net debt falling from -$270.9 million in 2023 to -$164.6 million by 2024.
Verano的股價爲4.12美元，市值爲14億美元。該公司的債務水平預計將下降，淨債務從2023年的-2.709億美元下降至2024年的-1.646億美元。
Comparative Analysis With Other MSOs
與其他多州運營商的比較分析
The report compares Verano with other multi-state operators (MSOs), providing valuable insights for investors. Verano's EV/EBITDA multiple for 2024 is 6.7x, in line with other major players like Green Thumb (OTC:GTBIF) at 9.0x and Curaleaf (OTC:CURLF) at 13.5x.
該報告將Verano與其他多州運營商進行比較，爲投資者提供有價值的見解。Verano在2024年的EV / EBITDA倍數爲6.7倍，與其他主要參與者（如綠拇指（OTC：GTBIF）的9.0倍和Curaleaf（OTC：CURLF）的13.5倍）持平。
Additionally, Ascend Wellness (OTC:AAWH) has a multiple of 5.5x, and Cresco Labs (OTC:CRLBF) is at 6.4x. These comparisons show Verano's relative valuation in the market, positioning it competitively among its peers.
此外，Ascend Wellness（OTC：AAWH）的倍數爲5.5倍，而Cresco Labs（OTC：CRLBF）爲6.4倍。這些比較顯示出Verano在市場上的相對估值，使其在同行中處於競爭地位。
Debt-to-EBITDA ratio is also favorable for Verano at 0.6x, compared to Curaleaf's higher leverage at 3.3x. This lower debt ratio indicates a more stable financial position, potentially reducing risk for investors.
債務/ EBITDA比率也對Verano有利，爲0.6倍，而Curaleaf的槓桿率較高，爲3.3倍。這種較低的債務比率表明更穩定的財務狀況，可能降低投資風險。
Sales Breakdown
銷售細分
Verano's retail and wholesale sales breakdown indicates a diverse revenue stream. Retail sales are projected at $741.4 million for 2023, with wholesale contributing $197 million. Geographical distribution of sales includes significant contributions from states like Florida ($222.4 million) and New Jersey ($178.8 million).
Verano的零售和批發銷售細分顯示出多元化的收入來源。預計2023年零售銷售額爲7.414億美元，批發銷售額爲1.970億美元。銷售的地理分佈包括來自佛羅里達州（2.224億美元）和新澤西州（1.788億美元）等州的重要貢獻。
Learn more about leading cannabis companies and stocks, at the Benzinga Cannabis Market Spotlight in New Jersey on June 17th! Grow your business, raise money, and capitalize on the booming NJ recreational market. Don't miss this must-attend event in New Brunswick. Secure your tickets now. Very few spots are left. Use the code "JAVIER20" for 20% off!
了解Benzi加拿大大麻市場聚光燈中的領先公司和股票，在6月17日的新澤西州Benzinga Cannabis Market Spotlight上！發展您的業務，籌集資金，並利用NJ休閒市場的繁榮。不要錯過這個必參加的活動在新布倫瑞克。立即購買門票。已經很少機會了。使用代碼“JAVIER20”可享受20％的折扣！
Photo: AI-Generated Image.
照片：AI生成的圖像。
譯文內容由第三人軟體翻譯。